Intelligent Bio Solutions Inc. (INBS) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
INBS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
INBS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 40.8% | -348.7% | -346.2% |
| 2024 | 45.8% | -330.5% | -326.4% |
| 2023 | 26.0% | -1002.1% | -845.9% |
| 2022 | - | - | - |
| 2021 | 100.0% | -281.4% | -355.3% |
Download Data
Export INBS earnings history in CSV or JSON format
Free sign-in required to download data
Intelligent Bio Solutions Inc. (INBS) Earnings Overview
As of May 8, 2026, Intelligent Bio Solutions Inc. (INBS) reported trailing twelve-month net income of -$11M, reflecting +68.7% year-over-year growth. The company earned $-11.88 per diluted share over the past four quarters, with a net profit margin of -346.2%.
Looking at the long-term picture, INBS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$340,000 in fiscal 2017.
Intelligent Bio Solutions Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including OPRX ($5M net income, 4.7% margin), QDEL (-$1.21B net income, -41.5% margin), CUE (-$27M net income, -96.9% margin), INBS has room to improve margins relative to the peer group. Compare INBS vs OPRX →
INBS Earnings vs Peers
Earnings metrics vs comparable public companies
INBS Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$11M | -4.1% | -$11M | $-20.00 | -346.2% | -348.7% |
| 2024 | -$10M | +4.5% | -$10M | $-63.80 | -326.4% | -330.5% |
| 2023 | -$11M | -28.0% | -$13M | $-105.80 | -845.9% | -1002.1% |
| 2022 | -$8M | -18.0% | -$8M | $-113.30 | - | - |
| 2021 | -$7M | -122.4% | -$6M | $-162.20 | -355.3% | -281.4% |
| 2020 | -$3M | +56.9% | -$3M | $-89.20 | -1676.2% | -1513.7% |
| 2019 | -$7M | -46.2% | -$6M | $-210.10 | - | - |
| 2018 | -$5M | -1376.5% | -$5M | $-146.00 | - | - |
| 2017 | $-340,000 | - | $-173,000 | $-9.90 | - | - |
See INBS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INBS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INBS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINBS — Frequently Asked Questions
Quick answers to the most common questions about buying INBS stock.
Is INBS growing earnings?
INBS EPS is $-11.88, with earnings growth accelerating to +68.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-11M.
What are INBS's profit margins?
Intelligent Bio Solutions Inc. net margin is -346.2%, with operating margin at -348.7%. Below-average margins reflect competitive or cost pressures.
How consistent are INBS's earnings?
INBS earnings data spans 2017-2025. The accelerating earnings trend is +68.7% YoY. Historical data enables comparison across business cycles.